Tokyo Tape
Sign in
← Delta-Fly Pharma

Annual report

4598.TEDINET S100OMGA
Period2021-04-01 → 2022-03-31
Filed2022-06-30
StandardJapan GAAP
ConsolidatedNo
Data checks11 of 11 passed
Key figures · 71
MetricValuePeriodScopeSource row
Operating income−¥961m2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥852m2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income−¥964m2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥859m2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income−¥1.6bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥671m2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥245m2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥964m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax−¥859m2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income−¥967m2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥863m2020-04-01 → 2021-03-31StandaloneProfit loss
Net income−¥1.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥674m2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income−¥246m2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.3bnat 2022-03-31StandaloneAssets
Total assets¥2.2bnat 2021-03-31StandaloneAssets
Total assets¥2.2bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.6bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥864mat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥91mat 2022-03-31StandaloneLiabilities
Total liabilities¥82mat 2021-03-31StandaloneLiabilities
Net assets / equity¥1.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥2.1bnat 2021-03-31StandaloneNet assets
Net assets / equity¥2.1bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥3.5bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥822mat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.3bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥2.1bnat 2021-03-31StandaloneCash and deposits
Cash & equivalents¥1.3bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.9bnat 2020-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥3.5bnat 2019-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥781mat 2018-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥940m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥727m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.6bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥585m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥100m2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥505,0002020-04-01 → 2021-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥13m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥120m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥875m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥100m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.3bn2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥293m2017-04-01 → 2018-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-178.582021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-187.342020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-348.322019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-170.162018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-71.22017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥227.41at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥390.87at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥456.47at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥801.93at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥228.15at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio93.1%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio96.1%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.1%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio98.2%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.2%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued5,419,600at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,314,600at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,504,600at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued4,369,600at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued5,635at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees12at 2022-03-31StandaloneNumber of employees
Employees11at 2021-03-31StandaloneNumber of employees
Employees13at 2020-03-31dStandaloneNumber of employees
Employees11at 2019-03-31dStandaloneNumber of employees
Employees11at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 731
ItemContextValueUnit
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember1268492000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember84375000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember87825000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember21332000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember20888000JPY
Compensations sgaPrior1YearDuration_NonConsolidatedMember48926000JPY
Compensations sgaCurrentYearDuration_NonConsolidatedMember72196000JPY
Taxes and dues sgaPrior1YearDuration_NonConsolidatedMember33305000JPY
Taxes and dues sgaCurrentYearDuration_NonConsolidatedMember34038000JPY
Patent costs sgaPrior1YearDuration_NonConsolidatedMember34450000JPY
Patent costs sgaCurrentYearDuration_NonConsolidatedMember48032000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)四国財務局長
Filing date cover pageFilingDateInstant2022-06-30
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第12期(自　2021年４月１日　至　2022年３月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ　株式会社
Company name in english cover pageFilingDateInstantＤｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ, Ｉｎｃ．
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　江島　淸
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の５
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)088－637－1055(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　管理部門担当　黒滝　健一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町３丁目11番５号日本橋ライフサイエンスビルディング２　６階
Telephone number nearest place of contact cover pageFilingDateInstant03－6231－1278
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　管理部門担当　黒滝　健一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE34318
Fund codeFilingDateInstant－
Security codeFilingDateInstant45980
Filer name in japaneseFilingDateInstant
Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ　株式会社
Filer name in englishFilingDateInstantDelta-Fly Pharma,Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2021-04-01
Current period end dateFilingDateInstant2022-03-31
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2022-03-31
Previous fiscal year start dateFilingDateInstant2020-04-01
Comparative period end dateFilingDateInstant2021-03-31
Previous fiscal year end dateFilingDateInstant2021-03-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 11 of 11 passed
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass